PropertyValue
?:abstract
  • To discuss the coagulation dysfunction in COVID-19 patients and to find new biomarkers to separate severe COVID-19 patients from mild ones. We use a retrospective analysis of 88 COVID-19 patients, and compare the coagulation function between severe and mild groups. We found the prothrombin time (PT), thrombin time (TT), D-dimer were significantly higher in the severe group (P < 0.05), and the highest area under the curve (AUC) is 0.91 for D-dimer, while the AUC of PT and TT were 0.80 and 0.61 respectively. We identified that D-dimer has a better value in predicting patients who are likely to develop into severe cases, with the sensitivity and specificity were 84.4% and 88.8%, respectively. D-dimer may be a good biomarker to separate the severe COVID-19 patients from the mild ones.
?:creator
?:doi
  • 10.1177/1076029620964868
?:doi
?:journal
  • Clin_Appl_Thromb_Hemost
?:license
  • cc-by-nc
?:pdf_json_files
  • document_parses/pdf_json/fb257e8cbc2f299246b56f22f2b4d0bfae1bbb74.json
?:pmc_json_files
  • document_parses/pmc_json/PMC7549161.xml.json
?:pmcid
?:pmid
?:pmid
  • 33030047.0
?:publication_isRelatedTo_Disease
?:sha_id
?:source
  • Medline; PMC
?:title
  • A Retrospective Analysis of the Coagulation Dysfunction in COVID-19 Patients
?:type
?:year
  • 2020-10-08

Metadata

Anon_0  
expand all